Skip to content

Reiki for Pain and Anxiety in People Living with Cancer: A Pilot Study of Effects and Patient Experiences

A Pilot Mixed-Methods Study of Reiki for Pain, Anxiety, and Patient Experience in People Living with Cancer

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000945325
Enrollment
40
Registered
2026-07-30
Start date
2026-08-03
Completion date
2026-10-26
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This pilot study is aiming to evaluate the effect of Reiki on pain, anxiety and patient experience in people living with cancer Who is it for? You may be eligible to join this study if you are aged 18 years or above, have been diagnosed with cancer (stage I – III) and experiencing cancer-related pain and/or anxiety. You also need to be English-speaking, sufficient to complete the survey, able to provide informed consent and be clinically stable at the time of participation. Study details All participants will receive a once-off free 30 min Reiki therapy session with a professional Reiki practitioner in the practitioner’s private practice. Participants will complete surveys at before and after the session to determine changes in anxiety, pain, wellbeing and experiences with Reiki therapy. This study will provide preliminary evidence to inform future research on Reiki as a supportive therapy for improving wellbeing among people living with cancer.

Interventions

Reiki is sometimes described as a “biofield therapy.” This means it focuses on the idea of energy in and around the body. Reiki aims to support the natural flow of this energy to help the body feel more balanced and calm. During a Reiki session, the practitioner aims to support this energy flow, while the person receiving Reiki simply relaxes. The Reiki practitioner places their hands lightly on or just above a person’s body. The goal is to support the body’s natural ability to heal itself. Perf

Reiki is sometimes described as a “biofield therapy.” This means it focuses on the idea of energy in and around the body. Reiki aims to support the natural flow of this energy to help the body feel more balanced and calm. During a Reiki session, the practitioner aims to support this energy flow, while the person receiving Reiki simply relaxes. The Reiki practitioner places their hands lightly on or just above a person’s body. The goal is to support the body’s natural ability to heal itself. Performed by Suzanne King, who has been a professional Reiki practitioner since 2019 and a Master / Teacher since 28 Oct 2024. Suzanne is a Member of the International Association of Reiki Professionals (IARP) and a Member of the International Institute for Complementary Therapists (IICT). Reiki is delivered face to face to individuals The Reiki therapy session will be 30 minutes duration, one-off The Reiki therapy will be delivered in a private clinic The participants will be provided with an appointment reminder prior to attending

Sponsors

University of Tasmania
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion criteria: • People aged 18 years and above • People diagnosed with all types of cancer (stage I – III). • English-speaking, sufficient to complete the survey • Able to provide informed consent • Clinically stable at the time of participation • Self reports experiencing pain and/or anxiety related to cancer or its treatment

Exclusion criteria

Exclusion criteria: • Paediatric patients • People diagnosed with stage IV cancer • Acute medical or psychiatric instability that would preclude safe participation. • Cognitive impairment (including from use of analgesia or other treatments) limiting capacity for informed consent or study participation

Outcome results

None listed

Source: ANZCTR · Data processed: Aug 10, 2026